References
- Jacques LB: Heparin from different sources. Lancet 2: 1262, 1972
- Bauer FB, Holveck MS: Heparin. (Letter) JAMA 228: 1636, 1974
- Walton PL, Ricketts CR, Bangham DR: Heterogeneity of heparin. Brit J Haematol 12: 310, 1966
- Silverglade A: Biological equivalence of beef lung and hog mucosal heparins. Curr Ther Res 18 (1 Pt 1): 91, 1975
- Salzman EW, Deykin D, Shapiro RM, et al: Management of heparin therapy: Controlled prospective trial. N Engl J Med 292: 1046. 1975
- Glazier RL, Crowell EB: Randomized prospective trial of continuous vs intermittent heparin therapy. JAMA 236: 1365, 1976
- Estes JW: The kinetics of heparin. Ann NY Acad Sci 179: 187, 1971
- Estes JW: The fate of heparin in the body. Curr Ther Res 18 (1 Pt 1): 45, 1975
- Reno WJ, Rotman M, Grumbine FC, et al: Evaluation of the BART test (a modification of the w hole-blood activated recalcification time test) as a means of monitoring heparin therapy. Am J Clin Pathol 61: 78, 1974
- Handley AJ: Heparin therapy: A simpler test of control. J Clin Pathol 27: 250, 1974
- Yin ET, Wessler S, Butler J V: Plasma heparin: A unique, practical, submicrogram-sensitive assay. J Lab Clin Med 81: 298, 1973
- Rosenberg RD: Heparin action. Circulation 49: 603, 1974
- Hirsh J: Treatment of venous thrombosis with heparin. In Kakkar VV, Thomas DP (Editors): Heparin, Chemistry and Clinical Usage. New York, Academic Press, Inc, 1976, p 175
- Basu D, Gallus A, Hirsh J, et al: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287: 324, 1972
- Coon WW, Willis PW 3d, Symons MJ: Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 170: 559, 1969
- Coon WW, Willis PW 3d: Thromboembolic complications during anticoagulant therapy. Arch Surg 105: 209, 1972
- Coon WW, Willis PW 3d: Recurrence of venous thromboembolism. Surgery 73: 823, 1973
- Coon WW, Willis PW 3d: Hemorrhagic complications of anticoagulant therapy. Arch Intern Med 133: 386, 1974
- O'Reilly RA, Aggeler PM: Studies on coumarin anticoagulant drugs, initiation of warfarin therapy without a loading dose. Circulation 38: 169. 1968
- Coon WW, Willis PW 3d: Some aspects of the pharmacology of oral anticoagulants. Clin Pharmacol Ther 11: 312, 1970
- Sevitt S, Innes D: Evidence against “rebound” thrombosis after stopping oral anticoagulant drugs. Lancet 2: 974, 1963
- Koch-Weser J, Sellers EM: Drug interactions with coumarin anticoagulants. N Engl J Med 285: 547. 1971
- Adverse interactions of drugs. Med Lett Drugs Ther 17: 17, 1975
- Rhodes GR, Dixon RH, Silver D: Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 136: 409, 1973
- Babcock RB, Dumper CW, Scharfman WB: Heparin-induced immune thrombocytopenia. N Engl J Med 295: 237, 1976
- Gregorius FK, Rand RW: Scanning electron microscopic observations of the common carotid artery of the rat. III. Heparin effect on platelets. Surgery 79: 584, 1976
- Pekçelen Y, Inceman S: Heparin and ristocetin-reduced platelet aggregation. (Letter) Br Med J 4: 101, 1975
- Eika C: The platelet aggregating effect of eight commercial heparins. Scand J Haematol 9: 480, 1972
- Griffith GC, Nichols G Jr, Asher JD, et al: Heparin osteoporosis. JAMA 193: 91, 1965